Brazil's SUS Public Health System and Mais Medicos — 2026-09-20
This health signal was created by a user. It may contain unverified medical claims. Always consult a qualified healthcare professional before making health decisions.
SUS wait times have surged to critical levels, with over 865,000 patients waiting in Mato Grosso and 610,000 in Rio Grande do Sul. Amidst these bottlenecks, the Ministry of Health is pushing for new governance rules for Farmácia Popular and expanding digital health infrastructure, while state candidates in Rio and São Paulo make healthcare queues a central campaign issue.
Brazil's SUS Public Health System and Mais Medicos — 2026-09-20
Mato Grosso and Rio Grande do Sul Report Massive SUS Waitlists
Data released by state health secretariats highlights severe bottlenecks in specialist care. In Mato Grosso, the "Transparência da Regulação" portal shows 865,575 patients currently waiting for procedures or consultations. Similarly, Rio Grande do Sul reports 610,242 users on the general SUS waiting list, with a dedicated data panel now tracking demand by specialty to manage expectations. These figures underscore the strain on federal-state funding models, as local systems struggle to absorb demand despite federal transfers.
Healthcare Queues Become Central Issue in Rio and São Paulo Elections
With elections approaching, political candidates are prioritizing healthcare wait times. In São Paulo, both Tarcísio de Freitas and Fernando Haddad have proposed unifying health data to better measure demand and increasing procedure volumes in high-pressure areas. In Rio de Janeiro, gubernatorial candidates are proposing reforms to primary care and increased hiring of professionals to reduce queues, signaling that SUS efficiency is a decisive electoral factor.
New Governance Rules for Farmácia Popular Announced
The Ministry of Health has finalized new regulatory frameworks for the Farmácia Popular do Brasil (PFPB) program. Portaria GM/MS nº 12.091, published in August but actively being implemented and discussed in September, alters the 2017 consolidation rules to establish new governance and participation standards for the program. This move aims to streamline drug access and financial controls within the popular pharmacy network, a key component of SUS medication distribution.
Judicialization of Health Surpasses Public Sector Lawsuits
For the first time since 2020, judicial requests for private health insurance coverage (saúde suplementar) are on track to exceed those for the public SUS system. Data from the National Council of Justice (CNJ) for the first half of 2026 shows that lawsuits regarding treatments, plan adjustments, and complaints against private insurers are leading the volume of new cases. This shift pressures the regulatory agency ANS and may divert legal and administrative resources away from public health disputes.
Local view
Agora RS highlights the transparency of the new "Painel de Dados da Regulação," which allows citizens to track their specific position in the 610,000-person waitlist, aiming to provide clarity amidst frustration. Meanwhile, Brasil de Fato criticizes the lack of articulation from the Minas Gerais state government, noting that patients face months of delay for exams and specialists due to poor coordination between municipal and state levels.
Context & numbers
- Waitlist Volume: Mato Grosso alone has 865,575 patients in the SUS queue; Rio Grande do Sul has 610,242.
- Digital Health Investment: The SUS digital strategy is backed by up to BRL 42 billion (USD 7.8 billion) in public and private investment through 2026, focusing on interoperability and data integration.
- New Incorporations: CONASS reported the publication of Portaria SCTIE/MS Nº 56 in September 2026, which makes decisions on incorporating new technologies into the SUS public, reflecting ongoing updates to the national formulary.
On the radar
- Mais Médicos Especialistas: The third cycle of the Mais Médicos Especialistas (PMM-E) project is active, with municipalities continuing to adhere to the program to expand specialist availability, following recent edital publications.
- Dengue Vaccination Strategy: The Ministry of Health continues to coordinate with states and municipalities to define vaccination strategies, facing limited dose supply from manufacturers and requiring careful allocation in endemic regions.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
